Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking and Finance Review - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Pharma drags London stocks lower after Trump's tariff blitz
    Finance

    Pharma drags London stocks lower after Trump's tariff blitz

    Published by Global Banking and Finance Review

    Posted on August 1, 2025

    2 min read

    Last updated: January 22, 2026

    Pharma drags London stocks lower after Trump's tariff blitz - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:London Stock Exchangefinancial markets

    Quick Summary

    Trump's tariffs on global partners hit London stocks, with FTSE 100 down 0.7% and healthcare shares leading the decline. AstraZeneca and GSK face pressure from drug price demands.

    Table of Contents

    • Impact of Trump's Tariffs on London Stocks
    • Healthcare Sector Reaction
    • Market Performance Overview
    • Trade Relations and Economic Outlook

    Healthcare Shares Weigh on London Stocks Amid Trump's Tariff Actions

    Impact of Trump's Tariffs on London Stocks

    (Reuters) -British equities slipped on Friday, pressured by healthcare shares, as investors woke up to U.S. President Donald Trump's fresh levies on dozens of countries and demands to lower prescription drug prices.

    Healthcare Sector Reaction

    The blue-chip FTSE 100 was down 0.7% as of 0915 GMT, on track to snap a six-week winning streak.

    Market Performance Overview

    The domestically focused midcap FTSE 250 fell nearly 1% and headed for its second straight weekly decline.

    Trade Relations and Economic Outlook

    Late on Thursday, Trump slapped steep tariffs on exports from dozens of trading partners including Canada, Brazil, India, Taiwan and Switzerland, pressing ahead with his plans to reorder the global economy.

    British healthcare stocks dropped the most, down 2.3%, after Trump sent letters to the leaders of 17 major pharmaceutical companies on Thursday, including AstraZeneca and GSK, outlining how they should slash U.S. prescription drug prices.

    AstraZeneca shed 3.4%, while GSK slipped 1.3%.

    Industrial Support Services sector fell 2.1% after Intertek Group missed its half-year organic revenue growth. The British product testing firm fell the most in the FTSE 100, down 7.7%.

    British Airways owner IAG dropped 2.1% after the airline group said it expected a slight rise in costs linked to air traffic control issues.

    Watches of Switzerland was the biggest drag on the FTSE 250, down 8%, after the U.S. imposed a 39% tariff on Swiss imports.

    Conversely, Melrose Industries rose 6.5% to the top of the benchmark index, after the defence company beat operating profit expectations on strong demand.

    Pearson rose 4.5% after the British education company forecast stronger growth in the second half.

    Meanwhile, Britain said the European Union will remove tariffs on key steel products under a quota system from Friday as part of a reset of ties and a recent deal to ease trade barriers.

    However, London is yet to conclude negotiations with the U.S. after both sides agreed in May to work toward removing tariffs on British steel exports.

    Also, data showed on Friday that British house prices rose slightly faster than expected in July.

    (Reporting by Sanchayaita Roy in Bengaluru; Editing by Sahal Muhammed)

    Key Takeaways

    • •Trump's tariffs impact global trade relations.
    • •FTSE 100 down 0.7% due to healthcare sector decline.
    • •AstraZeneca and GSK shares fall after Trump's drug price demands.
    • •Intertek Group sees significant revenue growth miss.
    • •Melrose Industries rises on strong profit expectations.

    Frequently Asked Questions about Pharma drags London stocks lower after Trump's tariff blitz

    1What is the FTSE 100?

    The FTSE 100 is a stock market index that represents the 100 largest companies listed on the London Stock Exchange, based on market capitalization.

    2What is a blue-chip stock?

    A blue-chip stock refers to shares in large, well-established, and financially sound companies that have a history of reliable performance and dividend payments.

    More from Finance

    Explore more articles in the Finance category

    Image for US oil prices fall ahead of US-Iran talks
    US oil prices fall ahead of US-Iran talks
    Image for UN chief calls New START expiration 'grave moment'
    UN chief calls New START expiration 'grave moment'
    Image for Bank of England set to hold rates pending clearer picture on inflation
    Bank of England set to hold rates pending clearer picture on inflation
    Image for Ukraine energy minister warns of more power cuts, possible Russian attacks
    Ukraine energy minister warns of more power cuts, possible Russian attacks
    Image for Boeing's defense unit to cut 300 jobs, Bloomberg News reports
    Boeing's defense unit to cut 300 jobs, Bloomberg News reports
    Image for Choppy markets threaten ECB's 'good place' but rates still firmly on hold
    Choppy markets threaten ECB's 'good place' but rates still firmly on hold
    Image for Australia's Maas Group to sell construction materials division for up to $1.2 billion
    Australia's Maas Group to sell construction materials division for up to $1.2 billion
    Image for Snap reports upbeat revenue as holiday season fuels ad sales
    Snap reports upbeat revenue as holiday season fuels ad sales
    Image for Qualcomm shares slide as memory chip shortage hits smartphone market
    Qualcomm shares slide as memory chip shortage hits smartphone market
    Image for Alphabet says capital spending in 2026 could double, cloud business booms
    Alphabet says capital spending in 2026 could double, cloud business booms
    Image for Fifty-five thousand Ukrainian soldiers killed on battlefield, Zelenskiy tells French TV
    Fifty-five thousand Ukrainian soldiers killed on battlefield, Zelenskiy tells French TV
    Image for Pandora to launch platinum-plated jewellery as silver prices soar
    Pandora to launch platinum-plated jewellery as silver prices soar
    View All Finance Posts
    Previous Finance PostCNH Industrial posts upbeat results, but tariffs cloud the rest of 2025
    Next Finance PostPPF stands firm on ProSieben offer after MFE raises bid